A University of Alabama at Birmingham (UAB) spinoff company, Yuva Biosciences, has closed a $7.5 million seed round intended to help the company continue its advances in addressing mitochondrial dysfunction – a major cause of aging.
Yuva Biosciences, a longevity company specializing in cosmeceuticals and pharmaceuticals, used artificial intelligence to sort through thousands of molecules, identifying some that could restore mitochondrial function. One, YuvaBio Y100, is the first that Yuva Biosciences has brought to market. 
Keshav K. Singh, Ph.D.
Yuva Biosciences is now partnering with BosleyMD, a hair restoration company, which is using YuvaBio Y100 as a key ingredient in some of the company’s newest hair regrowth products.
“We believe this is one of the biggest innovations in hair loss we’ve seen in 25 years,” said Ken Washenik, M.D., Ph.D., Chief Medical Officer at Bosley.
Yuva Biosciences was co-founded in 2019 by Keshav K. Singh, Ph.D., the Joy and Bill Harbert Endowed Chair in the Department of Genetics at UAB Heersink School of Medicine.
VentureSouth, one of the country’s largest angel investment networks, led the seed round.
For more information on Yuva Biosciences, visit the company’s website.